1
|
De Luca C, Felletti S, Franchina FA, Bozza D, Compagnin G, Nosengo C, Pasti L, Cavazzini A, Catani M. Recent developments in the high-throughput separation of biologically active chiral compounds via high performance liquid chromatography. J Pharm Biomed Anal 2024; 238:115794. [PMID: 37890321 DOI: 10.1016/j.jpba.2023.115794] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Revised: 10/10/2023] [Accepted: 10/11/2023] [Indexed: 10/29/2023]
Abstract
Bioactive compounds, including active pharmaceutical ingredients (APIs), are often chiral molecules where stereoisomers have different biological and therapeutic activity. Nevertheless, the preparation of these molecules can lead to racemic or scalemic mixtures (it is not trivial to produce just the optically pure compound). The evaluation of the enantiomeric purity of bioactive compounds, and therefore quality, is indeed of fundamental importance for regulatory scopes. Chiral high performance liquid chromatography (HPLC) is the gold standard technique to separate and to purify enantiomers. This comes from the wide availability of commercial chiral stationary phases (CSPs) and operational modes, which makes the technique extremely versatile. In recent years, the most relevant trend in the field of chiral analytical HPLC has been the development of CSPs suitable for fast or even ultrafast separations, thus favoring the high throughput screening of biologically active chiral compounds. This process has somehow lagged behind compared to achiral HPLC, due to a series of practical and fundamental issues. The experience has shown how in chiral chromatography even very basic concepts, such as the supposed kinetic superiority of core-shell (pellicular) particles over fully porous ones to improve the chromatographic efficiency, cannot be taken for granted. In this review, the most relevant fundamental and practical features that must be taken into consideration to design successful high-throughput, fast enantioseparations will be discussed. Afterwards, the main classes of CSPs and the most relevant, recent (last five-year) high-throughput applications in the field of the separation of chiral bioactive compounds (for pharmaceutical, forensic, food, and omics applications) will be considered.
Collapse
Affiliation(s)
- Chiara De Luca
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Simona Felletti
- Department of Environmental and Prevention Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Flavio Antonio Franchina
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Desiree Bozza
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Greta Compagnin
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Chiara Nosengo
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Luisa Pasti
- Department of Environmental and Prevention Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| | - Alberto Cavazzini
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy.
| | - Martina Catani
- Department of Chemical, Pharrmaceutical and Agricultural Sciences, University of Ferrara, via L. Borsari 46, Ferrara 44121, Italy
| |
Collapse
|
2
|
Lin J, Tsang C, Lieu R, Zhang K. Fast chiral and achiral profiling of compounds with multiple chiral centers by a versatile two-dimensional multicolumn liquid chromatography (LC–mLC) approach. J Chromatogr A 2020; 1620:460987. [DOI: 10.1016/j.chroma.2020.460987] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 02/16/2020] [Accepted: 02/19/2020] [Indexed: 01/19/2023]
|
3
|
Tantawy MA, Alweshahy S, Elshabasy DA, Youssef NF. Simultaneous Determination of Co-administrated Deflazacort, Aprepitant and Granisetron in Dosage Forms and Spiked Human Plasma by RP-HPLC/PAD. J Chromatogr Sci 2019; 57:790-798. [DOI: 10.1093/chromsci/bmz062] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Revised: 06/05/2019] [Indexed: 11/12/2022]
Abstract
Abstract
A selective reversed phase high performance liquid chromatography/photodiode array detector (RP-HPLC/PAD) method has been developed for simultaneous determination of the three co-administrated deflazacort, aprepitant and granisetron drugs used with chemotherapy. The three cited drugs have been chromatographed on C18 column using a mobile phase consisting of acetonitrile–0.2% v/v triethylamine (80:20 v/v, pH of 6.6 ± 0.05) with isocratic elution and monitored by photodiode array at 220 nm. International conference on harmonization (ICH) guidelines were followed to validate the developed method. Successful application of the developed method was assessed by the simultaneous determination of the studied drugs in pure forms, dosage forms and plasma samples in the ranges of 0.2–20, 0.4–40 and 0.2–20 μg/mL for deflazacort, aprepitant and granisetron, respectively.
Collapse
Affiliation(s)
- Mahmoud A Tantawy
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
| | - Soheir Alweshahy
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
| | - Dalia A Elshabasy
- Pharmaceutical Chemistry Department, National Organization for Drug Control and Research, 6 Abu Hazem St., Pyramids Avenue, P.O. 29, Giza, Egypt
| | - Nadia F Youssef
- Pharmaceutical Chemistry Department, National Organization for Drug Control and Research, 6 Abu Hazem St., Pyramids Avenue, P.O. 29, Giza, Egypt
| |
Collapse
|
4
|
Yehia AM, Elshabasy DA, Youssef NF. High-performance thin-layer chromatography for the simultaneous determination of co-administrated granisetron, aprepitant, and deflazacort used with chemotherapy: Application onto dosage forms and spiked plasma by liquid–liquid extraction. JPC-J PLANAR CHROMAT 2019. [DOI: 10.1556/1006.2019.32.2.9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Ali Mohamed Yehia
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
- Chemistry Department, School of Pharmacy and Pharmaceutical Industries, Badr University in Cairo, Badr City, 11829 Cairo, Egypt
| | - Dalia Abdelrazeq Elshabasy
- Pharmaceutical Chemistry Department, National Organization for Drug Control and Research, 6 Abu Hazem St., Pyramids Avenue, P.O. 29, Giza, Egypt
| | - Nadia Fayek Youssef
- Pharmaceutical Chemistry Department, National Organization for Drug Control and Research, 6 Abu Hazem St., Pyramids Avenue, P.O. 29, Giza, Egypt
| |
Collapse
|